The efficacy and safety of anticoagulants therapy in cardiovascular disease management in modern medicine
| bracu.degree.level | Undergraduate | |
| bracu.type.group | Student Works | |
| datacite.rights | Open Access | |
| dc.contributor.advisor | Sharmin, Sabrina | |
| dc.contributor.author | Ferdous, Jannatul | |
| dc.contributor.department | School of Pharmacy | |
| dc.date.accessioned | 2026-04-20T11:11:20Z | |
| dc.date.available | 2026-04-20T11:11:20Z | |
| dc.date.copyright | 2025 | |
| dc.date.issued | 2025-05 | |
| dc.description | Cataloged from PDF version of thesis. | |
| dc.description | Includes bibliographical references (pages 41-47). | |
| dc.description | This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2025. | en_US |
| dc.description.abstract | As cardiovascular diseases (CVDs) remain a major global health concern, ongoing advancements in therapeutic approaches are essential. Anticoagulant therapy is one of these strategies that have become an essential component for managing CVDs, providing significant advantages in terms of lowering thrombotic events and enhancing patient outcomes. This abstract presents a summary of the safety and effectiveness of anticoagulant therapy in the management of modern cardiovascular disease, combining data from guidelines, clinical trials, and recent literature. Cardiovascular care is constantly as shown by the development of anticoagulant agents, which have improved efficacy, safety profiles, and convenience. This research sets out to determine factors influencing therapeutic choice-making, evaluate safety profiles, investigate the effect of anticoagulant agents on clinical practice guide lines, and evaluate the efficacy of different anticoagulant agents through an in-depth review. | en_US |
| dc.description.degree | Bachelor of Pharmacy | |
| dc.description.statementofresponsibility | Jannatul Ferdous | |
| dc.format.extent | 47 pages | |
| dc.identifier.other | ID 18346067 | |
| dc.identifier.uri | http://hdl.handle.net/10361/27978 | |
| dc.language.iso | en | en_US |
| dc.publisher | BRAC University | en_US |
| dc.rights | BRAC University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. | |
| dc.subject | Cardiovascular disease | en_US |
| dc.subject | Anticoagulant therapy | en_US |
| dc.subject | Thromboembolism | en_US |
| dc.subject | Direct oral anticoagulant | en_US |
| dc.subject | Warfarin | en_US |
| dc.subject | Clinical guidelines | en_US |
| dc.subject | Safety profile | en_US |
| dc.subject | Clinical trial | en_US |
| dc.subject.lcsh | Clinical Trials. | |
| dc.subject.lcsh | Cardiovacular system--Physiology. | |
| dc.subject.lcsh | Thromboembolism. | |
| dc.title | The efficacy and safety of anticoagulants therapy in cardiovascular disease management in modern medicine | en_US |
| dc.type | Thesis | en_US |